Herzuma rolled out in the EU

Mundipharma says the Herzuma (trastuzumab) biosimilar rival to Roche’s Herceptin is now “available in Europe”, after launching the treatment for breast and gastric cancer in both the UK and Germany.

Mundipharma says the Herzuma (trastuzumab) biosimilar rival to Roche’s Herceptin is now “available in Europe”, after launching the treatment for breast and gastric cancer in both the UK and Germany.

Following a recommendation from the committee for medicinal products for human use (CHMP) within the European Medicines Agency (EMA) late...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Archive

More from Generics Bulletin